BIOLASE, Inc.

BIOL · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Assets
Cash & Equivalents$6,566$4,181$29,972$17,564
Short-Term Investments$0$0$0$0
Receivables$5,483$5,841$4,238$4,557
Inventory$11,433$15,884$12,929$11,157
Other Curr. Assets$1,381$3,053$2,215$3,965
Total Curr. Assets$24,863$28,959$49,354$35,110
Property Plant & Equip (Net)$7,044$6,046$2,784$2,758
Goodwill$2,926$2,926$2,926$2,926
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$268$255$220$231
Total NC Assets$10,238$9,227$5,930$5,915
Other Assets$0$0$0$0
Total Assets$35,101$38,186$55,284$41,025
Liabilities
Payables$6,065$5,786$3,309$2,651
Short-Term Debt$3,153$1,338$405$305
Tax Payable$452$432$558$165
Deferred Revenue$2,452$2,111$2,259$1,905
Other Curr. Liab.$7,541$8,140$7,313$6,197
Total Curr. Liab.$19,663$17,807$13,844$11,223
LT Debt$12,554$14,350$15,052$17,960
Deferred Rev, NC$256$418$329$374
Deferred Tax Liab, NC$0$0$0$384
Other NC Liab.$672$722$851$1,440
Total NC Liab.$15,685$15,490$16,232$19,774
Other Liabilities$0$0$0$0
Cap. Leases$1,660$1,897$1,854$2,079
Total Liabilities$35,348$33,297$30,076$30,997
Equity
Pref Stock$2,203$0$34$118
Common Stock$3$8$154$98
Retained Earnings-$316,800-$296,168-$267,534-$251,376
AOCI-$553-$733-$623-$385
Other Equity$314,900$301,782$293,177$261,573
Total Equity-$247$4,889$25,208$10,028
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$35,101$38,186$55,284$41,025
Net Debt$9,141$11,507-$14,515$701